BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17132724)

  • 1. Donor cell leukemia: insight into cancer stem cells and the stem cell niche.
    Flynn CM; Kaufman DS
    Blood; 2007 Apr; 109(7):2688-92. PubMed ID: 17132724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
    Ruiz-Delgado GJ; León Peña AA; Gómez-de-León A; Ruiz-Argüelles GJ
    Hematology; 2016 Sep; 21(8):470-3. PubMed ID: 26914843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
    Camacho V; McClearn V; Patel S; Welner RS
    Int J Hematol; 2017 May; 105(5):566-577. PubMed ID: 28176225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells.
    Lee GY; Jeong SY; Lee HR; Oh IH
    Sci Rep; 2019 Jan; 9(1):1007. PubMed ID: 30700727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
    Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
    Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
    Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].
    Kato M
    Rinsho Ketsueki; 2017; 58(7):813-817. PubMed ID: 28781279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
    Rizo A; Vellenga E; de Haan G; Schuringa JJ
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R210-9. PubMed ID: 16987886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis.
    Seshadri M; Qu CK
    Curr Opin Hematol; 2016 Jul; 23(4):339-45. PubMed ID: 27071022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor cell leukemia: a review.
    Wiseman DH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated genomic and single-cell transcriptomic analyses reveal clonal evolution and immune signature in donor cell leukemia after haploidentical allogeneic hematopoietic stem cell transplantation.
    Chen H; Zhao X; Pan W; Xiao H
    Leuk Lymphoma; 2023 Oct; 64(10):1681-1688. PubMed ID: 37424322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
    Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.
    Wang E; Hutchinson CB; Huang Q; Lu CM; Crow J; Wang FF; Sebastian S; Rehder C; Lagoo A; Horwitz M; Rizzieri D; Yu J; Goodman B; Datto M; Buckley P
    Am J Clin Pathol; 2011 Apr; 135(4):525-40. PubMed ID: 21411775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
    Engel N; Rovo A; Badoglio M; Labopin M; Basak GW; Beguin Y; Guyotat D; Ljungman P; Nagler A; Schattenberg A; Schroeder T; Schroyens W; Tischer J; Socie G; Kolb HJ; Tichelli A; Salooja N; Duarte RF;
    Leukemia; 2019 Feb; 33(2):508-517. PubMed ID: 30050122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric segregation and self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2.
    Ting SB; Deneault E; Hope K; Cellot S; Chagraoui J; Mayotte N; Dorn JF; Laverdure JP; Harvey M; Hawkins ED; Russell SM; Maddox PS; Iscove NN; Sauvageau G
    Blood; 2012 Mar; 119(11):2510-22. PubMed ID: 22174158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-renewal versus differentiation in hematopoietic stem and progenitor cells: a focus on asymmetric cell divisions.
    Giebel B; Bruns I
    Curr Stem Cell Res Ther; 2008 Jan; 3(1):9-16. PubMed ID: 18220918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations that drive leukemic stem cell self-renewal.
    van den Boom V; Horton SJ; Schuringa JJ
    J Stem Cells; 2012; 7(3):155-79. PubMed ID: 23619382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losing Sense of Self and Surroundings: Hematopoietic Stem Cell Aging and Leukemic Transformation.
    Verovskaya EV; Dellorusso PV; Passegué E
    Trends Mol Med; 2019 Jun; 25(6):494-515. PubMed ID: 31109796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-mediated microenvironment dysregulation in leukemia.
    Kumar B; Garcia M; Murakami JL; Chen CC
    Biochim Biophys Acta; 2016 Mar; 1863(3):464-470. PubMed ID: 26384870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.